Wellington Management Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $210M | Buy |
|
|||||
|
2025
Q2 | $155M | Sell |
|
|||||
|
2025
Q1 | $269M | Buy |
|
|||||
|
2024
Q4 | $377M | Sell |
|
|||||
|
2024
Q3 | $449M | Sell |
|
|||||
|
2024
Q2 | $629M | Buy |
|
|||||
|
2024
Q1 | $885M | Sell |
|
|||||
|
2023
Q4 | $984M | Buy |
|
|||||
|
2023
Q3 | $577M | Buy |
|
|||||
|
2023
Q2 | $607M | Sell |
|
|||||
|
2023
Q1 | $546M | Sell |
|
|||||
|
2022
Q4 | $453M | Sell |
|
|||||
|
2022
Q3 | $680M | Sell |
|
|||||
|
2022
Q2 | $522M | Sell |
|
|||||
|
2022
Q1 | $721M | Buy |
|
|||||
|
2021
Q4 | $583M | Buy |
|
|||||
|
2021
Q3 | $368M | Buy |
|
|||||
|
2021
Q2 | $677M | Buy |
|
|||||
|
2021
Q1 | $450M | Sell |
|
|||||
|
2020
Q4 | $601M | Buy |
|
|||||
|
2020
Q3 | $315M | Buy |
|
|||||
|
2020
Q2 | $341M | Buy |
|
|||||
|
2020
Q1 | $278M | Buy |
|
|||||
|
2019
Q4 | $132M | Buy |
|
|||||
|
2019
Q3 | $87.5M | Sell |
|
|||||
|
2019
Q2 | $130M | Buy |
|
|||||
|
2019
Q1 | $75.6M | Buy |
|
|||||
|
2018
Q4 | $206K | Buy |
|